{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:07:40Z","timestamp":1793210860540,"version":"4.5.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,9]]},"abstract":"<jats:p>This project sought to explore the potential association between medical history and the development of multiple sclerosis (MS) by conducting a retrospective study. This population-based case-control study included 200 MS cases and 2 control groups of 200 patients and healthy individuals each. Data was collected through face-to-face interviews, medical file reviews, and an electronic checklist. Multivariable analysis was used to calculate odds ratios and 95% confidence intervals to estimate the risk of each medical history on MS occurrences. Of 600 participants, 381 (63.5%) individuals were female. The mean age of the participants was 36.5\u2005\u00b1\u200511.9 years. The adjusted risks of MS were 4.40; 95% CI: 1.73 to 11.1 for measles and 4.75; 95% CI: 2.05 to 11 for amoxicillin consumption. The adjusted MS odds for autoimmune disease including 4.63; 95% CI: 0.35 to 60.6 for psoriasis and 7.15; 95% CI: 1.87 to 27.2 for myasthenia gravis. On the other hand, the calculated adjusted odds of MS occurrence were 0.14; 95% CI: 0.03 to 0.69 for seizure and 0.17; 95% CI: 0.02 to 1.49 for epilepsy. This study suggested that individuals with autoimmune diseases should be monitored more closely, as they may be at an increased risk of developing other autoimmune conditions, particularly MS.<\/jats:p>","DOI":"10.1097\/md.0000000000033906","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T14:16:24Z","timestamp":1686320184000},"page":"e33906","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Relationship between medical history and multiple sclerosis: A-case-control study"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6283-9467","authenticated-orcid":false,"given":"Fatemeh","family":"esfandiari","sequence":"first","affiliation":[{"name":"Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobin","family":"Ghazaiean","sequence":"additional","affiliation":[{"name":"Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Darvishi-Khezri","sequence":"additional","affiliation":[{"name":"Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Department of Research, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8138-7504","authenticated-orcid":false,"given":"Seyed Mohammad","family":"Baghbanian","sequence":"additional","affiliation":[{"name":"Neurology Department, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis \u2013 the plaque and its pathogenesis.","volume":"354","author":"Frohman","year":"2006","journal-title":"N Engl J Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000325368","article-title":"Are the prevalence and incidence of multiple sclerosis changing?","volume":"36","author":"Benito-Le\u00f3n","year":"2011","journal-title":"Neuroepidemiology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10072-021-05750-w","article-title":"Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis.","volume":"43","author":"Mirmosayyeb","year":"2022","journal-title":"Neurol Sci"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-020-01747-8","article-title":"Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999\u20132018.","volume":"20","author":"Almasi-Hashiani","year":"2020","journal-title":"BMC Neurol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1352458514564490","article-title":"A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis.","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult Scler"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","article-title":"Multiple sclerosis: risk factors, prodromes, and potential causal pathways.","volume":"9","author":"Ramagopalan","year":"2010","journal-title":"Lancet Neurol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-020-1618-6","article-title":"Does the multiple sclerosis (MS) map need to change again? an update of MS prevalence in Mazandaran province of Iran in 2018.","volume":"20","author":"Baghbanian","year":"2020","journal-title":"BMC Neurol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-022-02609-1","article-title":"Epidemiology of familial multiple sclerosis in Iran: a national registry-based study.","volume":"22","author":"Salehi","year":"2022","journal-title":"BMC Neurol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"e0235562","DOI":"10.1371\/journal.pone.0235562","article-title":"Age and sex-adjusted incidence and yearly prevalence of multiple sclerosis (MS) in Mazandaran province, Iran: An 11-years study.","volume":"15","author":"Cheraghmakani","year":"2020","journal-title":"PLoS One"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"e0246157","DOI":"10.1371\/journal.pone.0246157","article-title":"The nature of genetic and environmental susceptibility to multiple sclerosis.","volume":"16","author":"Goodin","year":"2021","journal-title":"PLoS One"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18103\/mra.v9i6.2413","article-title":"Genetic and environmental susceptibility to multiple sclerosis.","volume":"9","author":"Goodin","year":"2021","journal-title":"Med Res Arch"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1464-5491.2009.02743.x","article-title":"Seasonal variation of diagnosis of Type 1 diabetes mellitus in children worldwide.","volume":"26","author":"Moltchanova","year":"2009","journal-title":"Diabet Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1017\/S0317167100013688","article-title":"Traumatic injury and multiple sclerosis: a systematic review and meta-analysis.","volume":"40","author":"Warren","year":"2013","journal-title":"Can J Neurol Sci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000494257","article-title":"Medical history and multiple sclerosis: a population-based incident case-control study.","volume":"52","author":"Abdollahpour","year":"2019","journal-title":"Neuroepidemiology"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"11193","DOI":"10.3390\/ijms231911193","article-title":"Neuro-inflammation modulation and post-traumatic brain injury lesions: from bench to bed-side.","volume":"23","author":"Jacquens","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamaneurol.2014.3558","article-title":"Inflammation and neuroprotection in traumatic brain injury.","volume":"72","author":"Corps","year":"2015","journal-title":"JAMA Neurol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/ana.25061","article-title":"Concussion may not cause multiple sclerosis.","volume":"82","author":"Wijnands","year":"2017","journal-title":"Ann Neurol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.25036","article-title":"Concussion in adolescence and risk of multiple sclerosis.","volume":"82","author":"Montgomery","year":"2017","journal-title":"Ann Neurol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jns.2013.08.011","article-title":"Physical trauma and risk of multiple sclerosis: a systematic review and meta-analysis of observational studies.","volume":"336","author":"Lunny","year":"2014","journal-title":"J Neurol Sci"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/ane.12958","article-title":"Infectious exposure, antibiotic use, and multiple sclerosis: a population-based incident case-control study.","volume":"138","author":"Abdollahpour","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s10072-017-3080-9","article-title":"Multiple sclerosis and environmental risk factors: a case-control study in Iran.","volume":"38","author":"Abbasi","year":"2017","journal-title":"Neurol Sci"},{"key":"R23-20250504","first-page":"86","article-title":"Medical history risk factors in primary progressive multiple sclerosis: a case-control study.","volume":"20","author":"Maroufi","year":"2021","journal-title":"Curr J Neurol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-009-9367-2","article-title":"A population-based case\u2013control study on viral infections and vaccinations and subsequent multiple sclerosis risk.","volume":"24","author":"Ahlgren","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00415-016-8263-4","article-title":"Vaccines and multiple sclerosis: a systematic review.","volume":"264","author":"Mailand","year":"2017","journal-title":"J Neurol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/1099-1654(200009\/10)10:5<291::AID-RMV278>3.0.CO;2-U","article-title":"Transient virus infection and multiple sclerosis.","volume":"10","author":"Atkins","year":"2000","journal-title":"Rev Med Virol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jneuroim.2012.03.014","article-title":"Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome.","volume":"247","author":"Ahlgren","year":"2012","journal-title":"J Neuroimmunol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-0404.2008.01131.x","article-title":"Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations.","volume":"119","author":"Ahlgren","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/1352458510369146","article-title":"Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study.","volume":"16","author":"Langer-Gould","year":"2010","journal-title":"Mult Scler"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"69","DOI":"10.17712\/nsj.2021.1.20200107","article-title":"Risk factors of multiple sclerosis in Aseer region, Kingdom of Saudi Arabia a case-control study.","volume":"26","author":"Siddiqui","year":"2021","journal-title":"Neurosciences (Riyadh)"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/1352458514551780","article-title":"Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis.","volume":"21","author":"Simon","year":"2015","journal-title":"Mult Scler"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"102616","DOI":"10.1016\/j.msard.2020.102616","article-title":"Multicentric clinical and epidemiological comparison of neuromyelitis optica spectrum disorder with multiple sclerosis from India.","volume":"47","author":"Gupta","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"e28887","DOI":"10.1097\/MD.0000000000028887","article-title":"Newly diagnosed multiple sclerosis in a patient with ocular myasthenia gravis: a case report.","volume":"101","author":"Bong","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00000441-200601000-00004","article-title":"High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: a clinical and serologic study.","volume":"331","author":"Sthoeger","year":"2006","journal-title":"Am Med Sci"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.msard.2019.06.027","article-title":"Co-occurrence of multiple sclerosis and myasthenia gravis: a case report and review of immunological theories.","volume":"34","author":"Dehbashi","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1590\/S0004-282X2008000200023","article-title":"Myasthenia gravis and multiple sclerosis: an uncommon presentation.","volume":"66","author":"Lorenzoni","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis.","volume":"14","author":"Danikowski","year":"2017","journal-title":"J Neuroinflammation"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41582-021-00519-3","article-title":"The multiple sclerosis prodrome.","volume":"17","author":"Makhani","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S1474-4422(07)70132-1","article-title":"Autoimmune disease in families with multiple sclerosis: a population-based study.","volume":"6","author":"Ramagopalan","year":"2007","journal-title":"Lancet Neurol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000515682","article-title":"Antibiotic use and risk of multiple sclerosis: a nested case-control study in Emilia-Romagna region, Italy.","volume":"55","author":"Baldin","year":"2021","journal-title":"Neuroepidemiology"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.21873\/invivo.12186","article-title":"Dominant antibiotic consumption patterns might be associated with the prevalence of multiple sclerosis in European countries.","volume":"34","author":"Tern\u00c1k","year":"2020","journal-title":"In Vivo"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/aje\/kwj123","article-title":"Antibiotic use and risk of multiple sclerosis.","volume":"163","author":"Alonso","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4923062","article-title":"Baicalin downregulates RLRs signaling pathway to control influenza a virus infection and improve the prognosis.","volume":"2018","author":"Pang","year":"2018","journal-title":"Evid Based Complement Alternat Med"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.4049\/jimmunol.0900747","article-title":"Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis.","volume":"183","author":"Ochoa-Rep\u00e1raz","year":"2009","journal-title":"J Immunol"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","article-title":"Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.","volume":"6","author":"Versporten","year":"2018","journal-title":"Lancet Glob Health"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000961","article-title":"Improvement of comorbid psoriasis in patients With MS treated with natalizumab.","volume":"8","author":"Berkovich","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"100027","DOI":"10.1016\/j.nerep.2021.100027","article-title":"Rituximab induced psoriasis in a patient with multiple sclerosis: a case report and literature review.","volume":"1","author":"Molazadeh","year":"2021","journal-title":"Neuroimmunol Rep"},{"key":"R49-20250504","first-page":"8147451","article-title":"Risk factors associated with multiple sclerosis: a case-control study in Damascus, Syria.","volume":"2021","author":"Taan","year":"2021","journal-title":"Mul Scler Int"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/qjmed\/hcr012","article-title":"Factors predisposing to the development of multiple sclerosis.","volume":"104","author":"Young","year":"2011","journal-title":"QJM"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:06:01Z","timestamp":1746324361000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":49,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033906","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,9]]}}}